International
The Morning Science

What science found today

‹
 

Research

Wegovy Reduces BMI in Kids With Obesity as Young as 6

MedPage Today ·

Wegovy Reduces BMI in Kids With Obesity as Young as 6

The Brief

  • Results from the phase III STEP Young trial show children ages 6 to 11 with obesity lost significant weight on semaglutide (Wegovy).
  • The results were presented at ObesityWeek in National Harbor, Md.
  • Reported results are from the trial at week 68, measuring mean change in body mass index (BMI).

Why it matters

It provides trial evidence on a GLP-1 medication for obesity in children as young as 6, an age group with limited drug-trial data.

Who’s affected

  • clinicians treating children with obesity
  • parents of young children with obesity

(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. At week 68, mean body...

Timeline

  1. Phase III STEP Young trial results on Wegovy in children aged 6 to 11 presented at ObesityWeek

  2. MedPageToday.com - medical news for physicians

    Wegovy Reduces BMI in Kids With Obesity as Young as 6

How do you feel about this?

0 Comments